ENDRA Life Sciences (NDRA) EPS (Basic) Growth (3y) (2019 - 2026)
ENDRA Life Sciences (NDRA) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -33.21% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -4.60% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 10.70% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 21.28% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.47% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 253.03% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -0.71% |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | -5.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.49% |
| Dec 31, 2025 | -41.89% |
| Sep 30, 2025 | -24.47% |
| Jun 30, 2025 | -70.37% |
| Mar 31, 2025 | -198.40% |
| Dec 31, 2024 | 88.62% |
| Sep 30, 2024 | -441.75% |
| Jun 30, 2024 | -858.26% |
| Mar 31, 2024 | -1,856.82% |
| Dec 31, 2023 | -1.40% |
| Sep 30, 2023 | -1,576.00% |
| Jun 30, 2023 | -40.78% |
| Mar 31, 2023 | -47.39% |
| Dec 31, 2022 | 1.76% |
| Sep 30, 2022 | -33.28% |
| Jun 30, 2022 | -64.17% |
| Mar 31, 2022 | 42.59% |
| Dec 31, 2021 | -167.34% |
| Sep 30, 2021 | 55.91% |
| Jun 30, 2021 | 44.58% |